Doctor of Philosophy (PhD) in Medical Genetics, Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom 2011

Master of Sciences (MSc) in Medical Genetics, Institute of Genetic Medicine, Newcastle University, Newcastle, United Kingdom 2007

Bachelor of Science in Molecular Genetics, Ohio State University, United States of America, 2005

I lead advanced genomic and clinical research, focusing on chronic kidney diseases and diabetes-related complications. My responsibilities include designing and supervising impactful research projects, mentoring graduate students, ensuring ethical compliance in clinical studies, and fostering international collaborations to advance scientific discovery and healthcare solutions. Additionally, I contribute to academic excellence through teaching, curriculum development, and serving as an editor for leading scientific journals.

Visiting Scientist
Mayo Clinic Nephrology and Hypertension Division, USA
Dates: Ongoing

• Collaborating with global leaders in Autosomal Dominant Polycystic Kidney Disease (ADPKD) research to advance understanding of genetic contributors and clinical interventions.

• Enhancing communication skills with academic administrations and building networks with renowned institutions to promote collaborative scholarship opportunities.

   

Clinical Research Section Editor
Cell Press
Dates: Ongoing

• Reviewing, editing, and curating cutting-edge genomic medicine and clinical research content for global scientific dissemination.

   

Principal Investigator and Co-Investigator

• Spearheaded multiple research projects, including collaborations with esteemed organizations like Harvard University, Dasman Diabetes Institute, and the London School of Economics (LSE).

Member, Ethics Committee
Dasman Diabetes Institute (DDI), Kuwait
Dates: Ongoing

• Provided ethical oversight and guidance for clinical research projects conducted at DDI, ensuring adherence to international research ethics standards.

• Evaluated and approved study protocols involving human participants, prioritizing patient safety and the integrity of research practices.

   

Board Member
The Scientific Center, Kuwait
2013 – 2021

• Served on the board for eight years, including a one-year tenure as manager, overseeing strategic, academic, and financial initiatives.

As an Associate Professor of Genomic Medicine at the Health Sciences Center, Kuwait University, my research has centered on the genetic underpinnings of chronic kidney diseases, with significant contributions to the fields of Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Diabetic Nephropathy. My efforts have aimed at improving diagnosis, prognosis, and therapeutic strategies through detailed genetic analysis and innovative research approaches.

My teaching philosophy is deeply rooted in the integration of research and education, reflecting my extensive background in genomic medicine. I believe that by bringing research into the classroom, educators can offer students a vibrant, dynamic learning experience that not only imparts knowledge but also cultivates the skills necessary for innovation and discovery in medical sciences.

Research Articles 

ALI, H., NAIM, M., SENUM, S. R., ALSAHOW, A., BAHBAHANI, Y., ABU-FARHA, M., ABUBAKER, J., MOHAMMAD, A., AL-HUNAYAN, A., ASBEUTAH, A. M., ZAYED, M., DEVARAJAN, S., HUSSAIN, N., JOHN, S. E., CHANNANATH, A., THANARAJ, T. A., AL-ALI, M., ALMOUSAWI, M., AL-MULLA, F. & HARRIS, P. C. 2023b. The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait. Clin Kidney J, 16, 355-366.

ALI, H., MALIK, M. Z., ABU-FARHA, M., ABUBAKER, J., CHERIAN, P., NIZAM, R., JACOB, S., BAHBAHANI, Y., NAIM, M., AHMAD, S., AL-SAYEGH, M., THANARAJ, T. A., ONG, A. C. M., HARRIS, P. C. & AL-MULLA, F. 2024b. Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease. J Gene Med, 26, e3674.

ALI, H., ALAHMAD, B., SENUM, S. R., WARSAME, S., BAHBAHANI, Y., ABU-FARHA, M., ABUBAKER, J., ALQADDOUMI, M., AL-MULLA, F. & HARRIS, P. C. 2024. PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients. American Journal of Nephrology, 1-1.

ALI, H., AL-MULLA, F., HUSSAIN, N., NAIM, M., ASBEUTAH, A. M., ALSAHOW, A., ABU-FARHA, M., ABUBAKER, J., AL MADHOUN, A., AHMAD, S. & HARRIS, P. C. 2019. PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease. Sci Rep, 9, 4141.

SENUM, S. R., LI, Y. S. M., BENSON, K. A., JOLI, G., OLINGER, E., LAVU, S., MADSEN, C. D., GREGORY, A. V., NEATU, R., KLINE, T. L., AUDREZET, M. P., OUTEDA, P., NAU, C. B., MEIJER, E., ALI, H., STEINMAN, T. I., MRUG, M., PHELAN, P. J., WATNICK, T. J., PETERS, D. J. M., ONG, A. C. M., CONLON, P. J., PERRONE, R. D., CORNEC-LE GALL, E., HOGAN, M. C., TORRES, V. E., SAYER, J. A., GENOMICS ENGLAND RESEARCH CONSORTIUM, T. H. P. K. D. C. D. A. M., STUDIES, T. P. & HARRIS, P. C. 2022. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. Am J Hum Genet, 109, 136-156.

ALI, H., HUSSAIN, N., NAIM, M., ZAYED, M., AL-MULLA, F., KEHINDE, E. O., SEABURG, L. M., SUNDSBAK, J. L. & HARRIS, P. C. 2015b. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease. BMC Nephrol, 16, 26.

ALI, H., ABU-FARHA, M., ALSHAWAF, E., DEVARAJAN, S., BAHBAHANI, Y., AL-KHAIRI, I., CHERIAN, P., ALSAIRAFI, Z., VIJAYAN, V., AL-MULLA, F., AL ATTAR, A. & ABUBAKER, J. 2022a. Association of significantly elevated plasma levels of NGAL and IGFBP4 in patients with diabetic nephropathy. BMC Nephrol, 23, 64.

ALI, H., ABU-FARHA, M., HAMMAD, M. M., DEVARAJAN, S., BAHBAHANI, Y., AL-KHAIRI, I., CHERIAN, P., ALSAIRAFI, Z., VIJAYAN, V., AL-MULLA, F., ATTAR, A. A. & ABUBAKER, J. 2022b. Potential Role of N-Cadherin in Diagnosis and Prognosis of Diabetic Nephropathy. Front Endocrinol (Lausanne), 13, 882700.

ALI, H., ALAHMAD, B., AL-SHAMMARI, A. A., ALTERKI, A., HAMMAD, M., CHERIAN, P., ALKHAIRI, I., SINDHU, S., THANARAJ, T. A., MOHAMMAD, A., ALGHANIM, G., DEVERAJAN, S., AHMAD, R., EL-SHAZLY, S., DASHTI, A. A., SHEHAB, M., AL-SABAH, S., ALKANDARI, A., ABUBAKER, J., ABU-FARHA, M. & AL-MULLA, F. 2021b. Previous COVID-19 Infection and Antibody Levels After Vaccination. Front Public Health, 9, 778243.

ALI, H., ALSHUKRY, A., MARAFIE, S. K., ALRUKHAYES, M., ALI, Y., ABBAS, M. B., AL-TAWEEL, A., BUKHAMSEEN, Y., DASHTI, M. H., AL-SHAMMARI, A. A., ABU-FARHA, M., ABUBAKR, J. & AL-MULLA, F. 2021c. Outcomes of COVID-19: Disparities by ethnicity. Infect Genet Evol, 87, 104639.

ALI, H., ALTERKI, A., SINDHU, S., ALAHMAD, B., HAMMAD, M., AL-SABAH, S., ALGHOUNAIM, M., JAMAL, M. H., ALDEI, A., MAIRZA, M. J., HUSAIN, M., DEVERAJAN, S., AHMAD, R., CHERIAN, P., ALKHAIRI, I., ALKANDARI, A., ABUBAKER, J., ABU-FARHA, M. & AL-MULLA, F. 2021d. Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination. Front Immunol, 12, 752233.

ALAHMAD, B., AL-SHAMMARI, A. A., BENNAKHI, A., AL-MULLA, F. & ALI, H. 2020. Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters. Diabetes Care, 43, 3113-3116.

ALHAMAR, G., MADDALONI, E., AL SHUKRY, A., AL-SABAH, S., AL-HADDAD, M., AL-YOUHA, S., JAMAL, M., ALMAZEEDI, S., AL-SHAMMARI, A. A., ABU-FARHA, M., ABUBAKER, J., ALATTAR, A. T., ALOZAIRI, E., ALESSANDRI, F., D'ONOFRIO, L., LETO, G., MASTROIANNI, C. M., MIGNOGNA, C., PASCARELLA, G., PUGLIESE, F., ALI, H., AL MULLA, F., BUZZETTI, R. & POZZILLI, P. 2022. Development of a clinical risk score to predict death in patients with COVID-19. Diabetes Metab Res Rev, 38, e3526.

AL-MULLA, F., MOHAMMAD, A., AL MADHOUN, A., HADDAD, D., ALI, H., EAASWARKHANTH, M., JOHN, S. E., NIZAM, R., CHANNANATH, A., ABU-FARHA, M., AHMAD, R., ABUBAKER, J. & THANARAJ, T. A. 2021. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19. Heliyon, 7, e06133.

AL-SAYEGH, M., ALI, H., JAMAL, M. H., ELGINDI, M., CHANYONG, T., AL-AWADI, K. & ABU-FARHA, M. 2021. Mouse Embryonic Fibroblast Adipogenic Potential: A Comprehensive Transcriptome Analysis. Adipocyte, 10, 1-20.

AL-SHAMMARI, A. A., ALI, H., ALAHMAD, B., AL-REFAEI, F. H., AL-SABAH, S., JAMAL, M. H., ALSHUKRY, A., AL-DUWAIRI, Q. & AL-MULLA, F. 2021. The Impact of Strict Public Health Measures on COVID-19 Transmission in Developing Countries: The Case of Kuwait. Front Public Health, 9, 757419.

AL MADHOUN, A., ALI, H., ALKANDARI, S., ATIZADO, V. L., AKHTER, N., AL-MULLA, F. & ATARI, M. 2016. Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton's jelly mesenchymal stem cells. Stem Cell Res Ther, 7, 165.

AL MADHOUN, A., ALKANDARI, S., ALI, H., CARRIO, N., ATARI, M., BITAR, M. S. & AL-MULLA, F. 2018. Chemically Defined Conditions Mediate an Efficient Induction of Mesodermal Lineage from Human Umbilical Cord- and Bone Marrow- Mesenchymal Stem Cells and Dental Pulp Pluripotent-Like Stem Cells. Cell Reprogram, 20, 9-16.

AL MADHOUN, A., MARAFIE, S. K., HADDAD, D., MELHEM, M., ABU-FARHA, M., ALI, H., SINDHU, S., ATARI, M. & AL-MULLA, F. 2020. Comparative Proteomic Analysis Identifies EphA2 as a Specific Cell Surface Marker for Wharton's Jelly-Derived Mesenchymal Stem Cells. Int J Mol Sci, 21.

AL SHAWAF, E., ABU-FARHA, M., DEVARAJAN, S., ALSAIRAFI, Z., AL-KHAIRI, I., CHERIAN, P., ALI, H., MATHUR, A., AL-MULLA, F., AL ATTAR, A. & ABUBAKER, J. 2019. ANGPTL4: A Predictive Marker for Diabetic Nephropathy. J Diabetes Res, 2019, 4943191.

ALI, H., AL-YATAMA, M. K., ABU-FARHA, M., BEHBEHANI, K. & AL MADHOUN, A. 2015a. Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal Cells mediates changes in the expression profile of stemness markers. PLoS One, 10, e0122465.

ALI, H., BAYATTI, N., LINDSAY, S., DASHTI, A. A. & AL-MULLA, F. 2013. Directed differentiation of umbilical cord blood stem cells into cortical GABAergic neurons. Acta Neurobiol Exp (Wars), 73, 250-9.

ALI, H., BITAR, M. S., AL MADHOUN, A., MARAFIE, M. & AL-MULLA, F. 2017. Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer. PLoS One, 12, e0171690.

ALI, H., HUSSAIN, N., NAIM, M., ZAYED, M., AL-MULLA, F., KEHINDE, E. O., SEABURG, L. M., SUNDSBAK, J. L. & HARRIS, P. C. 2015b. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease. BMC Nephrol, 16, 26.

ALKHAIRI, I., CHERIAN, P., ABU-FARHA, M., MADHOUN, A. A., NIZAM, R., MELHEM, M., JAMAL, M., AL-SABAH, S., ALI, H., TUOMILEHTO, J., AL-MULLA, F. & ABUBAKER, J. 2019. Increased Expression of Meteorin-Like Hormone in Type 2 Diabetes and Obesity and Its Association with Irisin. Cells, 8.

ALSAHOW, A., ALHELAL, B., ALYOUSEF, A., ALQALLAF, A., MARZOUQ, A., NAWAR, H., FANOUS, G., ABDELATY, M., BAHBAHANI, Y., ALRAJAB, H., ALTERKAIT, A. & ALI, H. 2020. Renal Data from the Arab World Dialysis in Kuwait: 2013-2019. Saudi J Kidney Dis Transpl, 31, 826-830.

ALSAHOW, A., ALYOUSEF, A., NAWAR, H., ALHELAL, B., ALQALLAF, A., ALMUHAITEEB, A., ELSHARKAWI, Y., ALRAJAB, H., ALI, H. & KUMAR, R. 2022. Safety of Intravenous Iron in CKD Stage 3-5 Patients Not on Dialysis: A Retrospective Cohort Study. Can J Kidney Health Dis, 9, 20543581221130685.

ALSHAWAF, E., HAMMAD, M. M., MARAFIE, S. K., ALI, H., AL-MULLA, F., ABUBAKER, J. & MOHAMMAD, A. 2022. Discovery of natural products to block SARS-CoV-2 S-protein interaction with Neuropilin-1 receptor: A molecular dynamics simulation approach. Microb Pathog, 170, 105701.

ALSHUKRY, A., ALI, H., ALI, Y., AL-TAWEEL, T., ABU-FARHA, M., ABUBAKER, J., DEVARAJAN, S., DASHTI, A. A., BANDAR, A., TALEB, H., AL BADER, A., ALY, N. Y., AL-OZAIRI, E., AL-MULLA, F. & BU ABBAS, M. 2020. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait. PLoS One, 15, e0242768.

ALSHUKRY, A., BU ABBAS, M., ALI, Y., ALAHMAD, B., AL-SHAMMARI, A. A., ALHAMAR, G., ABU-FARHA, M., ABUBAKER, J., DEVARAJAN, S., DASHTI, A. A., AL-MULLA, F. & ALI, H. 2021. Clinical characteristics and outcomes of COVID-19 patients with diabetes mellitus in Kuwait. Heliyon, 7, e06706.

CHERIAN, P., AL-KHAIRI, I., JAMAL, M., AL-SABAH, S., ALI, H., DSOUZA, C., ALSHAWAF, E., AL-ALI, W., AL-KHALEDI, G., AL-MULLA, F., ABU-FARHA, M. & ABUBAKER, J. 2021. Association Between Factors Involved in Bone Remodeling (Osteoactivin and OPG) With Plasma Levels of Irisin and Meteorin-Like Protein in People With T2D and Obesity. Front Endocrinol (Lausanne), 12, 752892.

HADDAD, D., JOHN, S. E., MOHAMMAD, A., HAMMAD, M. M., HEBBAR, P., CHANNANATH, A., NIZAM, R., AL-QABANDI, S., AL MADHOUN, A., ALSHUKRY, A., ALI, H., THANARAJ, T. A. & AL-MULLA, F. 2021. SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains. PLoS One, 16, e0251368.

JALKH, N., CHOUERY, E., HAIDAR, Z., KHATER, C., ATALLAH, D., ALI, H., MARAFIE, M. J., AL-MULLA, M. R., AL-MULLA, F. & MEGARBANE, A. 2017. Next-generation sequencing in familial breast cancer patients from Lebanon. BMC Med Genomics, 10, 8.

JAMAL, M. H., ABU-FARHA, M., AL-KHALEDI, G., AL-SABAH, S., ALI, H., CHERIAN, P., AL-KHAIRI, I., ALOTAIBI, F., AL-ALI, W., BOSSO, M., DSOUZA, C., ABUBAKER, J. & AL-MULLA, F. 2020. Effect of sleeve gastrectomy on the expression of meteorin-like (METRNL) and Irisin (FNDC5) in muscle and brown adipose tissue and its impact on uncoupling proteins in diet-induced obesity rats. Surg Obes Relat Dis, 16, 1910-1918.

JAMAL, M. H., ALI, H., DASHTI, A., AL-ABBAD, J., DASHTI, H., MATHEW, C., AL-ALI, W. & ASFAR, S. 2015. Effect of epigallocatechin gallate on uncoupling protein 2 in acute liver injury. Int J Clin Exp Pathol, 8, 649-54.

JAMAL, M. H., ALOTAIBI, F., DSOUZA, C., AL-SABAH, S., AL-KHALEDI, G., AL-ALI, W., ALI, H., CHERIAN, P., AL-KHAIRI, I., DEVARAJAN, S., ABU-FARHA, M., AL-MULLA, F. & ABUBAKER, J. 2022. Changes in the expression of meteorin-like (METRNL), irisin (FNDC5), and uncoupling proteins (UCPs) after bariatric surgery. Obesity (Silver Spring), 30, 1629-1638.

MAHER, A., NUNEZ-TOLDRA, R., CARRIO, N., FERRES-PADRO, E., ALI, H., MONTORI, S. & AL MADHOUN, A. 2018. The Effect of Commercially Available Endodontic Cements and Biomaterials on Osteogenic Differentiation of Dental Pulp Pluripotent-Like Stem Cells. Dent J (Basel), 6.

NIZAM, R., AL-OZAIRI, E., GOODSON, J. M., MELHEM, M., DAVIDSSON, L., ALKHANDARI, H., AL MADHOUN, A., SHAMSAH, S., QADDOUMI, M., ALGHANIM, G., ALHASAWI, N., ABU-FARHA, M., ABUBAKER, J., SHI, P., HARTMAN, M. L., TAVARES, M., BITAR, M., ALI, H., AREFANIAN, H., DEVARAJAN, S., AL-REFAEI, F., ALSMADI, O., TUOMILEHTO, J. & AL-MULLA, F. 2018. Caveolin-1 Variant Is Associated With the Metabolic Syndrome in Kuwaiti Children. Front Genet, 9, 689.

NIZAM, R., AL-OZAIRI, E., GOODSON, J. M., MELHEM, M., DAVIDSSON, L., ALKHANDARI, H., AL MADHOUN, A., SHAMSAH, S., QADDOUMI, M., ALGHANIM, G., ALHASAWI, N., ABU-FARHA, M., ABUBAKER, J., SHI, P., HARTMAN, M. L., TAVARES, M., BITAR, M., ALI, H., AREFANIAN, H., DEVARAJAN, S., AL-REFAEI, F., ALSMADI, O., TUOMILEHTO, J. & AL-MULLA, F. 2019. Corrigendum: Caveolin-1 Variant Is Associated With the Metabolic Syndrome in Kuwaiti Children. Front Genet, 10, 221.

SHEHAB, M., ABU-FARHA, M., ALRASHED, F., ALFADHLI, A., ALOTAIBI, K., ALSAHLI, A., ALPHONSE THANARAJ, T., CHANNANATH, A., ALI, H., ABUBAKER, J. & ALMULLA, F. 2021a. Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study. J Clin Med, 10.

SHEHAB, M., ALRASHED, F., ABDULLAH, I., ALFADHLI, A., ALI, H., ABU-FARHA, M., CHANNANATH, A. M., ABUBAKER, J. A. & AL-MULLA, F. 2022a. Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-Term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study. Front Med (Lausanne), 9, 881027.

SHEHAB, M., ALRASHED, F., ALFADHLI, A., ALOTAIBI, K., ALSAHLI, A., MOHAMMAD, H., CHERIAN, P., AL-KHAIRI, I., ALPHONSE THANARAJ, T., CHANNANATH, A., ALI, H., ABU-FARHA, M., ABUBAKER, J. & AL-MULLA, F. 2021b. Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies. Vaccines (Basel), 9.

SHEHAB, M., ALRASHED, F., ALFADHLI, A., ALSAYEGH, A., ALDALLAL, U., ALSAYEGH, M., CHERIAN, P., ALKHAIR, I., THANARAJ, T. A., CHANNANATH, A., DASHTI, A. A., ALBANAW, A., ALI, H., ABU-FARHA, M., ABUBAKER, J. & AL-MULLA, F. 2022b. Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study. Front Med (Lausanne), 9, 933996.

MCGUCKIN, C., JURGA, M., ALI, H., STRBAD, M. & FORRAZ, N. 2008. Culture of embryonic-like stem cells from human umbilical cord blood and onward differentiation to neural cells in vitro. Nat Protoc, 3, 1046-55.

ALI, H., FORRAZ, N., MCGUCKIN, C. P., JURGA, M., LINDSAY, S., IP, B. K., TREVELYAN, A., BASFORD, C., HABIBOLLAH, S., AHMAD, S., CLOWRY, G. J. & BAYATTI, N. 2012. In vitro modelling of cortical neurogenesis by sequential induction of human umbilical cord blood stem cells. Stem Cell Rev Rep, 8, 210-23.

JURGA, M., FORRAZ, N., BASFORD, C., ATZENI, G., TREVELYAN, A. J., HABIBOLLAH, S., ALI, H., ZWOLINSKI, S. A. & MCGUCKIN, C. P. 2012. Neurogenic properties and a clinical relevance of multipotent stem cells derived from cord blood samples stored in the biobanks. Stem Cells Dev, 21, 923-36.

Reviews 

ABU-FARHA, M., AL-MULLA, F., THANARAJ, T. A., KAVALAKATT, S., ALI, H., ABDUL GHANI, M. & ABUBAKER, J. 2020. Impact of Diabetes in Patients Diagnosed With COVID-19. Front Immunol, 11, 576818.

ALI, H. & BAHBAHANI, H. 2010. Umbilical cord blood stem cells - potential therapeutic tool for neural injuries and disorders. Acta Neurobiol Exp (Wars), 70, 316-24.

Editorial 

ALI, H., PINTO E VAIRO, F., ALSAHOW, A. & ABU-FARHA, M. 2023c. Editorial: Advances in chronic kidney disease diagnosis and therapy. Frontiers in Medicine, 10.

ABU-FARHA, M., HOFMANN, S. & ALI, H. 2022. Editorial: Covid-19 and Diabetes. Front Endocrinol (Lausanne), 13, 933562.

ALI, H., ABU-FARHA, M. & HOFMANN, S. 2023a. Editorial: COVID-19 and diabetes, volume II. Front Endocrinol (Lausanne), 14, 1136997.

Letter to Editor 

ALI, H., AL-SHAMMARI, A. A., ALAHMAD, B. & AL-MULLA, F. 2021a. Advancing Risk Analysis of COVID-19 Clinical Predictors: The Case of Fasting Blood Glucose. Front Med (Lausanne), 8, 636065.